Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Lenvatinib Clinical Trials: A Systematic Review.

Detalles Bibliográficos
Publicado en:	Targeted Oncology Vol. 19; no. 2; pp. 161 - 174
Autores principales:	Crotty, Patrick, Kari, Karim, Hughes, Griffin K., Ladd, Chase, McIntire, Ryan, Gardner, Brooke, Peña, Andriana M., Ferrell, Sydney, Tuia, Jordan, Cohn, Jacob, Haslam, Alyson, Prasad, Vinay, Vassar, Matt
Formato:	Journal Article
Publicado:	Springer Nature Mar2024
Acceso en línea:	Ver este registro en EBSCOhost

Internet